Literature DB >> 11003636

The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B.

D D Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11003636     DOI： 10.1053/jhep.2000.18194

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

1.  Therapeutic implications of hepatitis C virus resistance to antiviral drugs.

Authors:  Jean-Michel Pawlotsky
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 2.  Future therapy for hepatitis B virus infection.

Authors:  Masahito Minami
Journal:  Clin J Gastroenterol       Date:  2015-08-12

3.  [4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Authors:  Markus Peck-Radosavljevic; Johann Deutsch; Peter Ferenci; Ivo Graziadei; Harald Hofer; Heidemarie Holzmann; Wolf-Dietrich Huber; Herman Laferl; Andreas Maieron; Rudolf Stauber; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2010-05-04       Impact factor: 1.704

4.  Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B.

Authors:  Themistoklis Vassiliadis; Kalliopi Patsiaoura; Konstantinos Tziomalos; Theodoros Gkiourtzis; Olga Giouleme; Nikolaos Grammatikos; Despoina Rizopoulou; Nikolaos Nikolaidis; Panagiotis Katsinelos; Eleni Orfanou-Koumerkeridou; Nikolaos Eugenidis
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

6.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

Review 7.  Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Authors:  Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 8.  Application of nucleoside analogues to liver transplant recipients with hepatitis B.

Authors:  Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Antiviral resistance and hepatitis B therapy.

Authors:  Marc G Ghany; Edward C Doo
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 10.  Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.

Authors:  Jean-Michel Pawlotsky; Geoffrey Dusheiko; Angelos Hatzakis; Daryl Lau; George Lau; T Jake Liang; Stephen Locarnini; Paul Martin; Douglas D Richman; Fabien Zoulim
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.